ArticleMaterials (Basel, Switzerland)2026
Synthesis and Application of Polyvinyl Alcohol (PVA) Micropowders for Antifouling Coatings.
Article in Materials (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
An effective and facile emulsion polymerization method was developed for the preparation of highly antibacterial hydrogel. In this study, polyhexamethylene guanidine (PHMG) was successfully cross-linked with polyvinyl alcohol (PVA) to form hydrogel micropowders with exceptional antibacterial properties. Subsequently, to improve the mechanical properties of the hydrogel, the hydrogel micropowders cross-linked with the antibacterial agent were combined with epoxy resin and coated onto stainless steel plates to form composite coatings. FT-IR spectroscopy was used to analyze the composition of the samples, confirming the successful reaction between PVA and PHMG. Bacterial inhibition assays demonstrated that the product exhibited an inhibition rate exceeding 99.99% against both
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.